abstract |
The present invention relates to 2,4-dioxo-imidazolidine derivatives of the general formula I. wherein R¹ to R⁴ and Y are defined as specified in the description, processes for their preparation and their use as inhibitors of platelet aggregation, metastasis of carcinoma cells and the binding of osteoclasts to the bone surfaces. |